Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
16.00
+0.28 (1.78%)
At close: Jan 8, 2025, 4:00 PM
16.03
+0.03 (0.19%)
After-hours: Jan 8, 2025, 7:30 PM EST
Organon & Co. Employees
Organon & Co. had 10,000 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
10,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$640,900
Profits / Employee
$130,100
Market Cap
4.12B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10,000 | 0 | - |
Dec 31, 2022 | 10,000 | 700 | 7.53% |
Dec 31, 2021 | 9,300 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
OGN News
- 20 days ago - Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 7 weeks ago - Organon: 7% Yield, 4x P/E, Big Upside Potential - Seeking Alpha
- 2 months ago - Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade) - Seeking Alpha
- 2 months ago - Organon & Co. (OGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Organon Reports Results for the Third Quarter Ended September 30, 2024 - Business Wire
- 2 months ago - Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% - Business Wire
- 2 months ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4 - Benzinga
- 2 months ago - 5 Stocks to Buy for a Harris Presidency - Kiplinger